Wilmington, Delaware, Feb. 13, 2025 (GLOBE NEWSWIRE) — Allied Market Research published a report, titled, “Hydrophobic Interaction Chromatography Market by Product and Service (Product and Service), Sample Type (Monoclonal Antibodies, Vaccines, Cell Culture Sample, Plasma & Serum Sample, and Others), Application (Protein & Antibody Purification, Vaccine Development, Drug Discovery, and Food & Dietary Supplement Development), and End User (Pharmaceutical & Biopharmaceutical Companies, Contract Research Organizations & Contract Manufacturing Organizations, Research & Academic Institutes, and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033″. According to the report, the “hydrophobic interaction chromatography market” was valued at $461.9 million in 2023, and is estimated to reach $952.9 million by 2033, growing at a CAGR of 7.5% from 2024 to 2033.
Request Sample of the Report on Global Hydrophobic Interaction Chromatography Market 2033 – https://www.alliedmarketresearch.com/request-sample/A325383
Prime determinants of growth
Increase in R&D expenditure in biopharmaceuticals, surge in demand for biologics & monoclonal antibodies (mAbs), and rise in adoption of biosimilars are the major factors that drive the growth of the hydrophobic interaction chromatography market. However, the lack of a skilled workforce and high initial investment & operating costs restrict market growth. Moreover, growth opportunities in emerging markets and technological advancements in hydrophobic interaction chromatography (HIC) are expected to open new avenues in the coming years.
Report coverage & details:
| Report Coverage | Details |
| Forecast Period | 2024–2033 |
| Base Year | 2023 |
| Market Size in 2023 | $461.9 million |
| Market Size in 2033 | $952.9 million |
| CAGR | 7.5% |
| No. of Pages in Report | 412 |
| Segments covered | Product & Service, Sample Type, Application, End User, and Region |
| Drivers |
|
| Opportunities |
|
| Restraint |
|
Want to Explore More, Connect to our Analyst – https://www.alliedmarketresearch.com/connect-to-analyst/A325383
The product segment held the largest market share in 2023.
By product and service, the product segment held the largest market share in 2023, accounting for more than four-fifths of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is expected to register the highest CAGR of 7.6% during the forecast period. This is attributed to growing demand for high-quality chromatography products, particularly in biopharmaceuticals and biotechnology industries. The increasing use of hydrophobic interaction chromatography for the purification of monoclonal antibodies, therapeutic proteins, and vaccines is driving the demand for advanced HIC resins and other chromatography products.
The monoclonal antibodies segment held the largest market share in 2023.
By sample type, the monoclonal antibodies segment held the largest market share in 2023, accounting for around two-fifths of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. The same segment is expected to register the highest CAGR of 7.9% during the forecast period. This is attributed to the increase in demand for monoclonal antibodies in the treatment of cancer, autoimmune disorders, and other chronic diseases, which drives the need for efficient and reliable purification methods such as hydrophobic interaction chromatography (HIC).
The protein and antibody purification segment held the largest market share in 2023.
By application, the protein and antibody purification segment held the largest market share in 2023, accounting for more than two-fifths of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the increase in demand for high-purity proteins and antibodies in the biopharmaceutical industry, particularly for the production of monoclonal antibodies, therapeutic proteins, and vaccines. In addition, the growing focus on biologics, biosimilars, and personalized medicine, along with stringent regulatory requirements for purity in biologics manufacturing, further contributes to the segment’s growth.
The pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023.
By end user, the pharmaceutical and biopharmaceutical companies segment held the largest market share in 2023, accounting for half of the hydrophobic interaction chromatography market revenue and is estimated to maintain its leadership status throughout the forecast period. This is attributed to the significant role of these companies play in the production of biologics, including monoclonal antibodies, therapeutic proteins, and vaccines, which require efficient purification techniques like hydrophobic interaction chromatography (HIC).
However, the contract research organizations and contract manufacturing organizations segment is expected to register the highest CAGR of 7.9% during the forecast period. This is attributed to the growing trend of outsourcing in the pharmaceutical and biotechnology industries, where CROs and CMOs are increasingly relied upon for their expertise in research, development, and manufacturing processes.
North America held the largest market share in 2023.
North America dominated the market share in 2023, accounting for around two-fifths of the hydrophobic interaction chromatography market revenue, owing to the presence of a well-established and advanced biopharmaceutical industry. Strong presence of pharmaceutical and biotechnology companies that extensively use hydrophobic interaction chromatography (HIC) for the purification of biologics, including monoclonal antibodies, therapeutic proteins, and vaccines.
However, Asia-Pacific is expected to register the highest CAGR of 8.2% during the forecast period owing to the increase in demand for biologics, biosimilars, and therapeutic proteins is driving the adoption of advanced purification technologies such as hydrophobic interaction chromatography (HIC). In addition, the region benefits from lower production costs, expanding contract research and manufacturing services, and growing investments in healthcare infrastructure and R&D. These factors, combined with supportive government policies and an increasing focus on improving regulatory standards, are contributing to the region’s robust growth in the HIC market.
For Purchase Related Queries/Inquiry – https://www.alliedmarketresearch.com/purchase-enquiry/A325383
Leading Market Players:
- Thermo Fisher Scientific Inc.
- Agilent Technologies, Inc.
- Sepax Technologies, Inc.
- Geno Technology, Inc.
- KNAUER Wissenschaftliche Gerate GmbH
- Bio-Rad Laboratories, Inc.
Trending Reports in Healthcare Industry:
Enteral Feeding Devices Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
AI in Healthcare Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
Endometrial Ablation Devices Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
Endotherapy Devices Market – Global Opportunity Analysis and Industry Forecast, 2024-2035
The report provides a detailed analysis of these key players in the hydrophobic interaction chromatography market. These players have adopted strategies such as, expansion, product launches, partnership, and others to increase their market share and maintain dominant shares in different regions. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to highlight the competitive scenario.
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
